Director, Global OEM & Licensing, Protein & Cell Analysis, Thermo Fisher Scientific
BIOGRAPHY
NOV 03, 2021 10:00 AM PDT
Streamline your path from immunodiagnostic development to commercialization
Speaker
Event Date & Time
Date: November 3, 2021
Time: 10:00am (PDT), 1:00pm (EDT)
Abstract
Developing an immunodiagnostic assay is a partnership from initial development through launch. Thermo Fisher Scientific’s Global OEM & Licensing (GOaL) team supports our partners’ development and commercialization of immunodiagnostic assays using a wide array of products and technologies. Our team of subject matter experts use their many years of experience to help guide your reagent selections and confirm that the commercial rights and necessary licenses are in place for the components being sourced. Working together with the GOaL team can help to ensure consistent performance and security of supply of important reagents. Post-launch, we work with our partners to maintain performance through features such as lot-to-lot consistency and change notification. This webinar will provide immunodiagnostics developers with the insight required to accelerate commercialization, as well as an understanding of the products, technologies, and capabilities at our various Centers of Excellence.
Learning Objectives:
- Discuss the selection of the optimal reagents to achieve your assay development goals
- Discuss how to obtain the necessary rights for using reagents in commercial applications
- Explore maximizing product performance, reproducibility, and security of supply
- Discuss the importance of providing accurate forecasts and plans to your suppliers to ensure reliable, consistent, product availability
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...